Please login to the form below

Not currently logged in
Email:
Password:

The impending threat of antibiotic resistance

Can Cinderella save us?

Antibiotic Research UK is the BIA's charity of 2015, but what does it intend to do?

How can pharma innovate in child and TYA cancer?

Online Physician Communitiesby Dr Tim Ringrose, M3 (EU)

Pharma deals during November 2014

deal watch image mergers acquisitions pharmaDeal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for November 2014

Deal Watch tableTable listing all the major pharma mergers, acquisitions and collaborations in the past month

Is pharma’s marketing model broken?

Online Physician Communitiesby Jenny Cowderoy, MD Communications, M3 (EU)

Webinars

Is co-creation the key to customer-centricity?

As pharma grapples with the need to becomemore doctor- and patient-centric, can co-creation help it better engage andconnect with its audience by redefining industry relationships with physicians and improve patient

Holistic market access and the importance of early engagement

Holistic market accessThere are two key elements in any successful strategy: knowing what to do, and knowing when to do it. Yet in terms of market access, there appears to be a

Digital: Fallacy or the Future Face of Pharma Marketing?

Digital: Fallacy or the Future Face of Pharma MarketingReach is one thing, trust is another. Digital channels may well be are growing in reach, but recent research from Cello Health Insight found that when it comes to trust,

UK payer perspectives: Is big data the future of market access?

'UK payer perspectives: Is big data the future of market access?’ will feature Paul Sutton, Director of Outcomes and Value, Commercial UK at Quintiles and Dr Junaid Bajwa, a GP

Country reports

Creating a 21st century life sciences ecosystem

UK life sciences minister George FreemanThe UK’s life sciences minister on how government and pharma can encourage NHS uptake and innovation

The rising prevalence of diabetes in Europe

The condition is still an unstoppable epidemic

The pharma business environment in the US

Business in the USATighter regulations, more pricing controls and increased international competition will drive market improvements

Video

Switching to a virtual healthcare system

babylon virtual health service Ali Parsa, CEO and founder of babylon, discusses the benefits of conducting healthcare consultations via a smartphone

The role of artificial intelligence in healthcare

Watson on jeopardy IBM's Amer Fasihi on the rise of Watson

The impact of new technology on healthcare

Mindy Daeschner PSHealth PMLiVE speaks to Mindy Daeschner, director of healthcare technology company PSHealth.

White papers

Improving Corporate Memory as a Patient Safety Strategy

An article by Lorri Zipperer

Building Marketing Capabilities for Competitive Advantage in 2014 & Beyond: Part 3 - Most Respected Companies for their Marketing Excellence

An insight into the leaders external to the healthcare industry and their views in marketing innovation.

More of the same: The importance of strategic communications planning for biosimilar entry

GCI Health's Hannah Morris considers the importance of strategic communications planning for biosimilar entry, a market anticipated to deliver between €8-26bn in savings across the European Union by 2020.

Remapping the market: Does Pharma's global model need a shake up?

For patients, carers and professionals, wherever they are in the world, digital technology is inherent in their everyday lives. Digital is, so to speak, a global language. The success of

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Excel Communications